Results 41 to 50 of about 9,855 (176)

The fight of innate immunity and abnormal cannabinoids against Candida infection

open access: yesBritish Journal of Pharmacology, EarlyView.
Candida species represent the most clinically significant fungal pathogens in humans, with invasive candidiasis carrying a mortality of 30%–40% in critically ill patients despite modern antifungal therapy. The innate immune system – through the coordinated and specific activities of neutrophils, macrophages, NK cells, mast cells and eosinophils ...
Prince Ofori   +2 more
wiley   +1 more source

Mitochondrial iron homeostasis is required for azole tolerance in Candida albicans

open access: yesThe FEBS Journal, EarlyView.
In Candida albicans, the deletion of MRS4, which encodes a mitochondrial iron importer, abolishes fluconazole tolerance and increases cidality during cotreatment with the iron chelator BPS, without altering MIC or synergy. Fluconazole‐treated mutants exhibit increased mitochondrial depolarisation, fragmentation and reduced mitochondrial density.
Wouter Van Genechten   +4 more
wiley   +1 more source

Is Candida auris sexual?

open access: yesPLOS Pathogens, 2020
We are grateful to Dr Gustavo Bravo Ruiz and Dr Delma Childers for critically reading the manuscript. Funding: We acknowledge funding from the Medical Research Council (MRC) Centre for Medical Mycology at the University of Exeter [grant number MR/P501955/1] (https://mrc.ukri.org/, https://www.exeter.ac.uk/medicalmycology/).
Zoe K. Ross, Alexander Lorenz
openaire   +5 more sources

Identification of Drug Resistant Candida auris [PDF]

open access: yesFrontiers in Microbiology, 2019
Candida auris is a multidrug resistant yeast, recognized as a cause of invasive infections and health care associated outbreaks around the world. C. auris is of great public health concern, due to its propensity for drug resistance, mode and pace of its transmission, and the possibility that biologic and epidemiologic factors could exacerbate worldwide
Milena Kordalewska, David S. Perlin
openaire   +3 more sources

Antimicrobial photodynamic therapy in Candida spp. biofilms: In vitro and in vivo protocols

open access: yesPhotochemistry and Photobiology, EarlyView.
This review addresses the critical challenges in translating in vitro antimicrobial photodynamic therapy protocols to in vivo models, with a particular focus on the hurdles of standardization. The vast diversity in photosensitizers and light parameters across different target cells and models requires a rigorous optimization process.
Lívia Mara Alves Figueiredo‐Godoi   +2 more
wiley   +1 more source

Stimuli‐Responsive Lipid‐Based Nanocarriers for Antimicrobial Therapy

open access: yesAdvanced Therapeutics, Volume 9, Issue 11, November 2026.
This manuscript demonstrated, through a scoping review of the literature, that modifying lipid nanocarriers with organic and inorganic excipients is a promising alternative to increase in vitro drug release of antimicrobial compounds under the studied stimulus and significantly enhance in vitro and in vivo antimicrobial activity compared to isolated ...
Brenda Maria Silva Bezerra   +5 more
wiley   +1 more source

Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan?

open access: yesJournal of the Formosan Medical Association, 2018
Candida auris is a recently identified multi-resistant Candida species, first reported in Japan in 2009, and poses a serious global health threat. Lack of awareness of this new Candida species and difficulties with laboratory identification have impacted
Po-Liang Lu   +11 more
doaj   +1 more source

Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris

open access: yesmSphere, 2018
Candida auris has recently emerged as an important, multidrug-resistant fungal pathogen of humans. Comparative studies indicate that despite high levels of genetic divergence, C.
Alison M. Day   +4 more
doaj   +1 more source

Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris

open access: yesmSystems, 2021
Candida auris is a recently described multidrug-resistant pathogenic fungus that is increasingly responsible for health care-associated outbreaks across the world. Bloodstream infections of this fungus cause death in up to 70% of cases.
Daniel Zamith-Miranda   +10 more
doaj   +1 more source

The diverse genomes of Candida auris

open access: yesThe Lancet Microbe
01 september ...
Hugh Gifford   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy